ID   NIPI3_CAEEL             Reviewed;         655 AA.
AC   G5EED4;
DT   22-JUL-2015, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 1.
DT   12-AUG-2020, entry version 70.
DE   RecName: Full=Protein nipi-3 {ECO:0000305};
DE   AltName: Full=No induction of peptide after drechmeria infection protein 3 {ECO:0000312|WormBase:K09A9.1};
GN   Name=nipi-3 {ECO:0000312|WormBase:K09A9.1};
GN   ORFNames=K09A9.1 {ECO:0000312|WormBase:K09A9.1};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000312|EMBL:ABW05091.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, DEVELOPMENTAL
RP   STAGE, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF ILE-307.
RX   PubMed=18394898; DOI=10.1016/j.cub.2008.02.079;
RA   Pujol N., Cypowyj S., Ziegler K., Millet A., Astrain A., Goncharov A.,
RA   Jin Y., Chisholm A.D., Ewbank J.J.;
RT   "Distinct innate immune responses to infection and wounding in the C.
RT   elegans epidermis.";
RL   Curr. Biol. 18:481-489(2008).
RN   [2] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: By regulating the up-regulation in the epidermis of
CC       antimicrobial peptides nlp-29 and nlp-31, plays a role in resistance to
CC       fungal infection. {ECO:0000269|PubMed:18394898}.
CC   -!- TISSUE SPECIFICITY: Expressed in epidermis, pharynx, intestine, a
CC       subset of head neurons and motoneurons. {ECO:0000269|PubMed:18394898}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the 3-fold stage embryo.
CC       {ECO:0000269|PubMed:18394898}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown results in a loss of nlp-
CC       29 expression upon fungal infection. No other obvious phenotype.
CC       {ECO:0000269|PubMed:18394898}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU043523; ABW05091.1; -; mRNA.
DR   EMBL; BX284606; CAB01883.3; -; Genomic_DNA.
DR   RefSeq; NP_510573.3; NM_078172.6.
DR   STRING; 6239.K09A9.1; -.
DR   EPD; G5EED4; -.
DR   PaxDb; G5EED4; -.
DR   EnsemblMetazoa; K09A9.1.1; K09A9.1.1; WBGene00010700.
DR   GeneID; 181650; -.
DR   KEGG; cel:CELE_K09A9.1; -.
DR   CTD; 181650; -.
DR   WormBase; K09A9.1; CE42581; WBGene00010700; nipi-3.
DR   eggNOG; ENOG502TG0H; Eukaryota.
DR   HOGENOM; CLU_422256_0_0_1; -.
DR   InParanoid; G5EED4; -.
DR   OMA; FTAHVLP; -.
DR   OrthoDB; 846202at2759; -.
DR   PhylomeDB; G5EED4; -.
DR   Reactome; R-CEL-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-CEL-165158; Activation of AKT2.
DR   Reactome; R-CEL-199418; Negative regulation of the PI3K/AKT network.
DR   Reactome; R-CEL-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-CEL-5218920; VEGFR2 mediated vascular permeability.
DR   SignaLink; G5EED4; -.
DR   PRO; PR:G5EED4; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00010700; Expressed in pharyngeal muscle cell (C elegans) and 5 other tissues.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0031434; F:mitogen-activated protein kinase kinase binding; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0050832; P:defense response to fungus; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0043405; P:regulation of MAP kinase activity; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR024104; Tribbles/Ser_Thr_kinase_40.
DR   PANTHER; PTHR22961; PTHR22961; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Nucleotide-binding; Reference proteome.
FT   CHAIN           1..655
FT                   /note="Protein nipi-3"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000433603"
FT   DOMAIN          200..470
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   NP_BIND         206..214
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         235
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MUTAGEN         307
FT                   /note="I->N: In fr4; susceptibility to fungal infection
FT                   characterized by a severe loss of nlp-29 and nlp-31
FT                   expression and a decrease in survival. Animals have a
FT                   temperature-sensitive reduction in size. In absence of
FT                   infection, reduced survival rate."
FT                   /evidence="ECO:0000269|PubMed:18394898"
SQ   SEQUENCE   655 AA;  75748 MW;  8A19F1933A9F59AA CRC64;
     MARTKCKTKT VANPRTGVRK TAKDLSEPVR QDAVSRRRPT TLPFVGNTSS RPRVFYDVLA
     KKNVVFPNVK AEYHYRVRNA PKIDPKNFGT TLPICYSSIG PAKTLELRPL GRLPPHIIKA
     LNDHYVQLTR GSMVPAADLY NNGDHPAEQR IPTMLNENEY LRLIQELEEE EKSKQFSATS
     SSAPHVNPYS AQHLVNGEII GIFVIYGTGL VTRAVCSQTR EMFTAHVLPE WKASKVIDVI
     RRLQIPTDIS SMTADEIRLS ELCISKRMEI IKSNDRYILM NPCESATIHS YATERLDEIT
     ENDVMSIYQK VVEIVRFCHS RKVILQNFKP RSFYLKKDAH NKWVVRPCFL QDMSCEEDQS
     EAQFTRRSVC VPFMAPEMLT AESRTHHSYS TELWGLGVLL YILLTGKYPF HENSMPLLFR
     TIKFKQHRWP FNFISSKSRN IVNMLLKKAP ATRMNLEDLW NQVNGDFPEI RCRSNIILKK
     QDMIVKMDLF EMYYNTYKDR LLPKNVLPMY EEMKACRNDS TILTEMAKRD FRSIQEQMKR
     RIETKPTEYQ TLVMQVRLQQ INQLFFEKEV SQAQKQHRAP RLVQLKCSDI SKELLLPGDI
     YPISEHYHPS QQPVDKVVYK LLSDANSLAF PTVMKGTVPK SYPPPVFKGL DISPS
//
